Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aesica, the global contract development and manufacturing organisation (CDMO), has appointed Sven Thomas and David Ross as business development managers. Their appointment is the next phase in the company’s international drive to increase sales from ...
read more
-- 100 Contract Research and Contract Manufacturing Organizations will be exhibiting at this year's September 17-19, 2013 Pharma ChemOutsourcing Show at the Jersey Shore reported Apaporis LLC, the organizer. The companies offer a wide range of ...
read more
As part of OsoBio’s quality control department, the microbiology and chemistry laboratories that Larese now directs are responsible for environmental monitoring, analytical method development, and testing all incoming raw materials, components, and ...
read more
AMRI announced today that Susan Collins has been promoted to Director of Business Development for North American Discovery Services, reporting to Christopher Conway, Vice President, Business Development. In this new role, Ms. Collins is responsible ...
read more
Ash Stevens, Inc. (ASI), a leading provider of global contract pharmaceutical drug substance development and API (Active Pharmaceutical Ingredient) manufacturing services, announces the U.S. Food and Drug Administration (FDA) has approved ASI's ...
read more
Catalent Pharma Solutions, a leading global drug delivery technology and advanced supply solutions company, has announced a major expansion of its controlled release drug manufacturing facility in Winchester, Kentucky. The company is to invest nearly...
read more
11 June 2013 - Recipharm AB is pleased to announce that it is working with Vectura Group plc to provide access to its licence for the regulatory dossier of Asmasal® for the Chinese regulatory authorities as part of the Chinese market approval process...
read more
Following the success of one of its key client partnered products, Craigavon-based pharmaceutical company Almac, has announced the commercial manufacturing expansion. Together with the recent completion of a new non-GMP drug development facility at ...
read more
On June 18, 2013 a Technical Conference on Sterile Manufacturing, organized by ISPE Spain, will be held at Telstar’s Corporate Headquarters and Life Sciences facility in Terrassa (Barcelona). This conference is focused on the latest developments in ...
read more
AMRI, a leading global contract research and manufacturing organization, has announced that the Board of Directors has unanimously voted to separate the role of Chairman and Chief Executive Officer and has named William S. Marth, an active member of ...
read more
Boehringer Ingelheim has signed with Zhangjiang Biotech & Pharmaceutical Base Development Company in Pudong, Shanghai a strategic alliance agreement and contract to build a cGMP biopharmaceuticals facility. The new site will provide full range of ...
read more
ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business.
read more
UPM Pharmaceuticals, a Baltimore, Maryland-based drug development and contract manufacturer, announced today that they will be acquiring the 500,000 square-foot commercial manufacturing facility that Pfizer Inc. (PFE) currently operates in Bristol, ...
read more
For the first time, Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, will showcase its biological-based ingredients and technologies at CPhI China. The company’s Hyasis™, Recombumin® and biocatalysis products will feature ...
read more
Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Recopharma, a biotechnology company developing ophthalmic products, today announce an agreement to supply a human Fc fusion protein using...
read more